In silico detection of potential inhibitors from vitamins and their derivatives compounds against SARS-CoV-2 main protease by using molecular docking, molecular …
COVID-19 is a new infectious disease caused by SARS-COV-2 virus of the coronavirus
Family. The identification of drugs against this serious infection is a significant requirement …
Family. The identification of drugs against this serious infection is a significant requirement …
[HTML][HTML] Theoretical molecular docking study of the structural disruption of the viral 3CL-protease of COVID19 induced by binding of capsaicin, piperine and curcumin …
LA Gonzalez-Paz, CA Lossada, LS Moncayo… - 2020 - europepmc.org
The global pandemic caused by infections of the new coronavirus (COVID-19) makes it
necessary to find possible less toxic and easily accessible therapeutic agents. In this study …
necessary to find possible less toxic and easily accessible therapeutic agents. In this study …
[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2
K Kodchakorn, Y Poovorawan, K Suwannakarn… - Journal of Molecular …, 2020 - Elsevier
The widespread problem of a 2019-novel coronavirus (SARS-CoV-2) strain outbreak in
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19
A Swargiary, S Mahmud, MA Saleh - Journal of Biomolecular …, 2022 - Taylor & Francis
COVID-19 and its causative organism SARS-CoV2 that emerged from Wuhan city, China
have paralyzed the world. With no clinically approved drugs, the global health system is …
have paralyzed the world. With no clinically approved drugs, the global health system is …
Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
I Aanouz, A Belhassan, K El-Khatabi… - Journal of …, 2021 - Taylor & Francis
The new Corona-virus, recently called the severe acute respiratory syndrome Coronavirus
(SARS-CoV-2) appears for the first time in China and more precisely in Wuhan (December …
(SARS-CoV-2) appears for the first time in China and more precisely in Wuhan (December …
[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore… - Eurasian Journal of …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
[HTML][HTML] In silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors
H Hashem - 2020 - europepmc.org
The huge attack of coronavirus disease 2019 (COVID-19) over all the world forces the
researcher around the world to study the crystal structure of the main protease M pro (3 …
researcher around the world to study the crystal structure of the main protease M pro (3 …
In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus
P Eleftheriou, D Amanatidou, A Petrou, A Geronikaki - Molecules, 2020 - mdpi.com
The coronavirus disease, COVID-19, caused by the novel coronavirus SARS-CoV-2, which
first emerged in Wuhan, China and was made known to the World in December 2019 turned …
first emerged in Wuhan, China and was made known to the World in December 2019 turned …
[HTML][HTML] Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A …
MR Rameshkumar, P Indu, N Arunagirinathan… - Saudi journal of …, 2021 - Elsevier
An outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been
recognized as a global health concern. Since, no specific antiviral drug is proven effective …
recognized as a global health concern. Since, no specific antiviral drug is proven effective …
相关搜索
- sars cov main protease
- molecular docking main protease
- molecular docking sars cov
- admet profiling main protease
- molecular docking admet profiling
- admet profiling sars cov
- potent inhibitor sars cov2
- molecular docking silico detection
- silico detection main protease
- sars cov silico detection
- admet profiling silico detection
- flavonoid compounds main protease
- sars cov flavonoid compounds
- silico evaluation protease inhibitors
- covid 19 main protease
- covid 19 sars cov2